The Institute of Cancer Research, London, is one of the world’s most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years.
Our donors and supporters play a vital role in helping researchers at the ICR to make the discoveries that defeat cancer.
The Enterprise Unit has many industrial partners and works with them to transform ideas into new products for the benefit of cancer patients.
Our 2018 drug access report, 'From Patent to Patient', highlights the progress that is being made with discovering exciting new cancer medicines
The ICR is a college of the University of London, and educating and training the next generation of cancer researchers and clinicians is a core part of our mission.
At the ICR we are researching how to treat the differences between cancers – an approach known as personalised medicine.
Our mission is to make the discoveries that defeat cancer. We are driven by a desire to understand the genetics and biology of cancer and to apply that knowledge to maximise clinical impact. We also want to attract the best minds in the world and create a non-limiting and fully inclusive environment for them.
We've selected a range of discoveries from 2018/19 – chosen because they illustrate the quality and breadth of our basic, translational and clinical research and our ambitions under the ICR's research strategy.
The ICR is led by Chief Executive, Professor Paul Workman — an expert in cancer drug discovery.
We are world leaders in identifying cancer genes, discovering cancer drugs and developing precision radiotherapy.
Together with our hospital partner The Royal Marsden NHS Foundation Trust, we are rated as one of the top centres for cancer research and treatment worldwide.
As well as being as world-class research institute, the ICR is a higher education institution and a college of the University of London. We came top in the league table of university research quality compiled from the Research Excellence Framework (REF 2014).
The ICR has charitable status and relies on support from partner organisations, charities, donors and the general public.
For more than 100 years, the ICR has been pioneering discoveries into cancer and its treatment.
The Institute of Cancer Research works to influence policy development in high-priority areas and to give the ICR a voice on relevant policy issues.
We also support staff who are engaging the public and coordinate opportunities to make young people aware of the opportunities for careers in science.
Our values – developed together as an organisation – make it clear how each and every one of us work to meet our mission – to make the discoveries that defeat cancer.
Here in London, our scientists conduct world-leading research every day. Our mission? To defeat cancer.
We always want to hear from people who have a cancer story to share.
Get in touch and help raise awareness of our research.
The Annual Report and Accounts provides the ICR's accounts for the end of each financial year.
We are building a state-of-the-art drug discovery centre to create more and and better cancer drugs
Our report asks how we can best harness advances in science to bring innovative drugs to patients. It is designed to help us reshape the landscape for drug discovery and development – and create tomorrow’s cancer treatments.
What’s coming for cancer in the 2020s
Tell me more about telomeres: how ‘basic’ science can help us treat cancer
‘Cure or nothing’ doesn’t capture the realities of modern cancer research and treatment
Contact us to find out more about the ICR.